Anticancer agent 230 (example 65) is a caseinolytic protease P ( ClpP ) activator with anticancer activity. Anticancer agent 230 is able to induce the degradation of mitochondrial proteins in SUM159 and MDA-MB-231 triple-negative breast cancer cells in a time-dependent manner.